DRUG — BRIGHT MINDS BIOSCIENCES INC
As of Q2 2026, 25 SEC-registered investment managers reported holding DRUG (BRIGHT MINDS BIOSCIENCES INC) in their latest 13F filings, with a combined reported value of $147.28M across 2.10M shares. That is -25.5% by share count (-720.52K shares) versus the previous quarter, while reported value moved -28.4%. Ownership is concentrated: the five largest holders account for 79.3% of reported value and the top ten for 93.9%.
Compared with the prior quarter, 6 opened new positions, 17 added to existing stakes, 2 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
DRUG is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Janus Henderson Group history | Q1 2026 | 1.28M | $93.52M | 0.05% | Add |
| BlackRock Inc history | Q2 2026 | 686.18K | $48.17M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 345.05K | $24.22M | 0.03% | Add |
| Point72 Asset Management history | Q2 2026 | 327.42K | $22.98M | 0.03% | New |
| Wellington Management Group history | Q2 2026 | 171.31K | $12.03M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 133.69K | $9.38M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 104.15K | $7.31M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 66.74K | $4.69M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 66.53K | $4.67M | 0.00% | New |
| Vanguard Group history | Q4 2025 | 48.58K | $3.79M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 42.47K | $2.98M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 26.97K | $1.89M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 18.60K | $1.31M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 18.03K | $1.27M | 0.00% | Add |
| D. E. Shaw & Co history | Q1 2026 | 15.45K | $1.13M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 15.54K | $1.09M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 14.90K | $1.05M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 9.61K | $674.34K | 0.00% | New |
| Franklin Resources history | Q2 2026 | 8.02K | $563.00K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q2 2026 | 7.85K | $551.16K | 0.00% | Add |
New Positions (Q2 2026)
- Point72 Asset Management 327.42K sh · $22.98M
- Citadel Advisors 66.53K sh · $4.67M
- Two Sigma Investments 9.61K sh · $674.34K
- Franklin Resources 8.02K sh · $563.00K
- Arrowstreet Capital 7.20K sh · $505.37K
- JPMorgan Chase & Co 4.78K sh · $330.54K
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 1.28M sh · $93.52M
- D. E. Shaw & Co sold 15.45K sh · $1.13M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q4 2023 | Q1 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | — | — | — | — | — | 1 | 1 | 678 | 209.68K | 234.12K | 394.04K | 621.93K | 686.18K |
| Balyasny Asset Management | — | — | — | — | — | — | — | — | — | — | — | — | — | 186.92K | 225.41K | 297.16K | 345.05K |
| Point72 Asset Management | — | — | — | — | — | — | — | — | — | — | 135.19K | 135.02K | 135.02K | 105.02K | — | — | 327.42K |
| Wellington Management Group | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 13.69K | 136.68K | 171.31K |
| Goldman Sachs Group | — | — | — | — | — | — | — | — | — | — | — | 22.22K | — | — | 48.55K | 74.37K | 133.69K |
| Geode Capital Management | — | — | — | — | — | — | — | — | — | — | — | — | 57.52K | 57.90K | 63.55K | 88.72K | 104.15K |
| Millennium Management | — | — | — | — | — | — | — | — | — | — | 40.38K | 192.56K | 111.37K | 76.68K | 194.44K | 52.83K | 66.74K |
| Citadel Advisors | — | — | — | — | — | — | — | — | 17.83K | — | — | 6.88K | — | 6.48K | — | — | 66.53K |
| Northern Trust Corp | — | — | — | — | — | — | — | — | — | — | — | — | 25.63K | 27.21K | 25.57K | 37.38K | 42.47K |
| Bank of America Corp | — | — | — | 10.65K | — | — | — | — | — | — | 4.79K | 5.42K | 4.73K | 7.04K | 15.07K | 19.42K | 26.97K |
| Morgan Stanley | — | — | — | — | — | — | — | — | — | — | 167.64K | 156.55K | 162.07K | 192.87K | 132.12K | 132.76K | 18.60K |
| Charles Schwab Investment Management | — | — | — | — | — | — | — | — | — | — | — | — | 11.60K | 11.60K | 12.46K | 15.32K | 18.03K |
| UBS Group AG | 1.56K | 3.45K | 7.28K | 14.83K | 5.21K | 10.90K | 2.10K | 622 | — | 3.41K | 10.16K | 11.54K | 1.91K | 1.59K | 13.81K | 13.28K | 15.54K |
| BNY Mellon | — | — | — | — | — | — | — | — | — | — | — | — | 8.70K | 10.07K | 9.99K | 13.25K | 14.90K |
| Two Sigma Investments | — | — | — | 11.07K | — | — | — | — | — | — | — | — | — | 10.71K | 2.60K | — | 9.61K |
| Franklin Resources | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 8.02K |
| Fidelity Management & Research (FMR) | — | — | — | — | — | — | — | — | — | — | — | — | 79 | 651 | 1.11K | 819 | 7.85K |
| Deutsche Bank AG | — | — | — | — | — | — | — | — | — | — | — | — | 5.49K | 619 | 4.26K | 6.26K | 7.81K |
| Arrowstreet Capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 7.20K |
| Wells Fargo & Co | — | — | — | — | — | — | — | — | — | — | — | — | 2.38K | 2.83K | 5.52K | 2.53K | 6.76K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details